company

FANA APOTEK AS

5221 NESTTUN

Return on Equity
39,93 %
Current Ratio
0,86
Debt-to-Equity Ratio
−0,84
Key figures (NOK)2022
Revenue14 139 000
Net Income−979 000
Total Assets2 723 000
Total Equity−2 452 000
Income (NOK)2022
Revenue14 139 000
Expenditure15 120 000
Operating Profit−980 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Earnings Before Tax−979 000
Tax0
Net Income−979 000
Balance (NOK)2022
Total Fixed Assets40 000
Total Current Assets2 683 000
Total Assets2 723 000
Total Retained Equity−3 706 000
Total Equity−2 452 000
Total Long-Term Debt2 059 000
Total Current Debt3 116 000
Total Equity and Debt2 723 000
Cash flow (NOK)2022
Sales Income14 245 000
Other Income−105 000
Revenue14 139 000
Cost of Goods Sold10 440 000
Salary Costs3 150 000
Depreciation117 000
Impairment0
Expenditure15 120 000
Operating Profit−980 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Dividends0
Net Income−979 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures40 000
Total Tangible Assets40 000
Total Fiancial Fixed Assets0
Total Fixed Assets40 000
Stock964 000
Total Investments0
Cash, Bank1 223 000
Total Current Assets2 683 000
Total Assets2 723 000
Total Equity−2 452 000
Short-Term Group Debt0
Total Long-Term Debt2 059 000
Creditors2 480 000
Unpaid Taxes271 000
Dividends0
Other Current Debt365 000
Total Current Debt3 116 000
Total Equity and Debt2 723 000
Financial indicators2022
Return on Equity39,93 %
Debt-to-Equity Ratio−0,84
Operating Profit Margin−6,93 %
Current Ratio0,86
Quick Ratio1,25
Equity Ratio−0,9
Gross Profit Margin26,16 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English